10.07.2013
- British pharmaceutical company AstraZeneca has agreed its first research partnerships in Cambridge for cancer treatments ahead of its relocation to the university city by 2016. The...
10.07.2013
- GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody...
02.07.2013
- Onyx Pharmaceuticals, whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer and...
28.06.2013
- Merck Serono, the biopharmaceutical division of Germany-based Merck KGaA, has created a dedicated immune-oncology innovation platform integrating research, early development and...
22.04.2013
- AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...
04.03.2013
- An Indian patent appeals board dismissed on Monday Bayer's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar...
14.12.2012
- Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could...
21.11.2012
- Indian drugmaker Cipla plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic...
